LOS ANGELES, Nov. 29, 2016 /PRNewswire/ -- Time Magazine has included new health and wellness cannabis-startup, hmbldt, among its top 25 inventions of 2016, claiming hmbldt is poised to offer an alternative to conventional pills and medications moving forward. It's a rare but significant moment for the cannabis industry to have a conventional and mainstream media outlet such as Time Magazine recognize the growth of medical cannabis and the role it is poised to play as the category continues to forge ahead in surpassing $50 billion over the next 10 years.
"We are thrilled the cannabis community received this recognition," said Matt Seashols, co-founder and president of hmbldt. "It is the result of decades of relentless hard work from farmers and advocates committed to educating people about the science and medicinal capabilities of cannabis; including the network of 250 family farms in Humboldt partnered with hmbldt to deliver solutions for sleep, pain relief and other targeted quality of life benefits."
Having only launched two months prior to being included within Time's list, hmbldt is seeing a tremendous amount of growth in its inaugural market of California and is looking to expand into Washington and other states in Q1 2017. The growth shows that hmbldt's positioning as a health and wellness company and commitment to targeted formulas in precise doses has broad appeal and is serving an unmet need in the market.
"At hmbldt, we isolate specific compounds present in cannabis to develop our custom formulas for each patient need state," said Samantha Miller, chief science officer for hmbldt and founder of Pure Analytics Laboratory. "I am confident that no other cannabis company has worked so diligently with scientific research on multiple formulas to positively impact patients' lives."
hmbldt is a health and wellness company dedicated to providing safe, targeted and effective cannabis-based solutions to millions of people. hmbldt helps patients receive the therapeutic benefits of the cannabis plant while mitigating the risk of intoxication. Informed by cannabis research studies, cannabis analytics and patient data, hmbldt's scientists develop precise formulations of compounds found in cannabis to deliver health benefits through their proprietary vaporizing device, the hmbldt dose pen, and solve specific patient need states. The result is a consistent, reliable and targeted experience. To learn more, visit www.hmbldt.com.
Contact: Derek McCarty